使用mRNA、DNA和蛋白递送Salp14策略的蜱免疫研究
研究以豚鼠为模型,比较mRNA脂质纳米颗粒(LNP)、质粒DNA和重组蛋白三种平台递送Salp14抗原诱导蜱免疫的效果。含salp14的mRNA-LNP接种后在蜱攻击时更早出现蜱叮咬部位红斑且更明显,体液和细胞免疫应答针对Salp14羧基端25氨基酸区域。研究表明疫苗平台可影响豚鼠蜱免疫的发生。
要点
- mRNA-LNP接种组蜱叮咬后红斑出现更早且更明显,优于DNA或蛋白免疫。
- 蜱免疫相关体液和细胞应答针对Salp14羧基端25氨基酸区域。
- 抗原递送平台可影响豚鼠蜱免疫的发生。
核心结论
- 疫苗平台可影响豚鼠蜱免疫的发生。
- mRNA-LNP可能有助于在蜱叮咬部位诱发红斑,这是获得性蜱抵抗最重要的早期标志之一。
- 含蜱基因的mRNA-LNP是开发可能预防特定蜱传疾病疫苗的有用平台。
研究设计与样本
- 研究以豚鼠为模型,利用Salp14作为模型抗原,比较mRNA脂质纳米颗粒(LNP)、质粒DNA或重组蛋白平台诱导蜱免疫的效果。
主要发现
- 含salp14的mRNA-LNP接种组在蜱攻击后蜱叮咬部位出现红斑的时间早于DNA或蛋白免疫组,且红斑更明显。
- 通过抗体应答和皮肤试验测定,蜱免疫相关的体液和细胞应答针对Salp14蛋白羧基端的25氨基酸区域。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Guinea pigs exposed to multiple infestations with Ixodes scapularis ticks develop acquired resistance to ticks, which is also known as tick immunity. The I. scapularis salivary components that contribute to tick immunity are likely multifactorial. An anticoagulant that inhibits factor Xa, named Salp14, is present in tick saliva and is associated with partial tick immunity. A tick bite naturally releases tick saliva proteins into the vertebrate host for several days, which suggests that the mode of antigen delivery may influence the genesis of tick immunity. We therefore utilized Salp14 as a model antigen to examine tick immunity using mRNA lipid nanoparticles (LNPs), plasmid DNA, or recombinant protein platforms. salp14 containing mRNA-LNPs vaccination elicited erythema at the tick bite site after tick challenge that occurred earlier, and that was more pronounced, compared with DNA or protein immunizations. Humoral and cellular responses associated with tick immunity were directed towards a 25 amino acid region of Salp14 at the carboxy terminus of the protein, as determined by antibody responses and skin-testing assays. This study demonstrates that the model of antigen delivery, also known as the vaccine platform, can influence the genesis of tick immunity in guinea pigs. mRNA-LNPs may be useful in helping to elicit erythema at the tick bite site, one of the most important early hallmarks of acquired tick resistance. mRNA-LNPs containing tick genes is a useful platform for the development of vaccines that can potentially prevent selected tick-borne diseases.
引用
- Matias J, Kurokawa C, Sajid A, et al. Tick immunity using mRNA, DNA and protein-based Salp14 delivery strategies. Vaccine. 2021. PMID: 34862075. doi:10.1016/j.vaccine.2021.11.003
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。